Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new

Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new

Abstract For metastatic soft tissue sarcoma (STS) patients not eligible for surgery, systemic treatments, including standard chemotherapy and newer biological compounds, still play the most relevant role in the management of the disease. An anthracycline and alkylating agent combination has formed t...

Full description

Bibliographic Details
Main Authors: Anna Maria Frezza, Silvia Stacchiotti, Alessandro Gronchi
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Medicine
Subjects:
Sarcoma
Advanced sarcoma
Metastatic sarcoma
Chemotherapy
Tyrosine kinase inhibitors
VEGF inhibitors
Online Access:http://link.springer.com/article/10.1186/s12916-017-0872-y

Internet

http://link.springer.com/article/10.1186/s12916-017-0872-y

Similar Items